Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli

Open Biology

Volumn 6, Issue 4, 2016, Pages

  Kay, Emily J ^a   Yates, Laura E ^a   Terra, Vanessa S ^a   Cuccui, Jon ^a   Wren, Brendan W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Capsular polysaccharide; Glycoengineering; Streptococcus pneumoniae; Synthetic glycobiology; Vaccine

Indexed keywords

BACTERIAL POLYSACCHARIDE; LIPOPOLYSACCHARIDE; TRANSPOSON;

BACTERIAL CAPSULE; BACTERIAL GENE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GENE LOCUS; GENETIC RECOMBINATION; GENETICS; IMMUNOBLOTTING; METABOLISM; MUTATION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TRANSPOSON;

BACTERIAL CAPSULES; BIOSYNTHETIC PATHWAYS; DNA TRANSPOSABLE ELEMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GENES, BACTERIAL; GENETIC LOCI; IMMUNOBLOTTING; LIPOPOLYSACCHARIDES; MUTATION; POLYSACCHARIDES, BACTERIAL; RECOMBINATION, GENETIC; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84971596956     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.150243     Document Type: Article

References (75)

1. O'Brien KL et al. 2009 Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374, 893-902. (doi:10.1016/S0140-6736(09)61204-6)
2. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MCC, Nahm MH. 2007 Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J. Clin. Microbiol. 45, 1225-1233. (doi:10.1128/JCM.02199-06)
3. Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, Abeygunwardana C, Nahm MH. 2012 Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J. Biol. Chem. 287, 27885-27894. (doi:10.1074/jbc.M112.380451)
4. Calix JJ, Nahm MH. 2010 A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J. Infect. Dis. 202, 29-38. (doi:10.1086/653123)
5. Ko KS, Baek JY, Song J-H. 2013 Capsular gene sequences and genotypes of 'serotype 6E' Streptococcus pneumoniae isolates. J. Clin. Microbiol. 51, 3395-3399. (doi:10.1128/JCM.01645-13)
6. Oliver MB, van der Linden MPG, Küntzel SA, Saad JS, Nahm MH. 2013 Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units. J. Biol. Chem. 288, 25 976-25 985. (doi:10.1074/jbc.M113.480152)
7. Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG. 2004 Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190, 1203-1211. (doi:10.1086/423820)
8. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. 2000 Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 30, 100-121. (doi:10.1086/313608)
9. Imöhl M, Möller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O. 2015 Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany. BMC Infect. Dis. 15, 61. (doi:10.1186/s12879-015-0787-1)
10. Mueller JE et al. 2012 Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults. PLoS ONE 7, e52464. (doi:10.1371/journal.pone.0052464)
11. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. 2003 Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187, 1424-1432. (doi:10.1086/374624)
12. Melin M, Trzciński K, Meri S, Käyhty H, Väkeväinen M. 2010 The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect. Immun. 78, 5262-5270. (doi:10.1128/IAI. 00740-10)
13. Melin M, Jarva H, Siira L, Meri S, Käyhty H, Väkeväinen M. 2009 Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect. Immun. 77, 676-684. (doi:10.1128/IAI.01186-08)
14. Hathaway LJ et al. 2012 Capsule type of Streptococcus pneumoniae determines growth phenotype. PLoS Pathog. 8, e1002574. (doi:10.1371/journal.ppat.1002574)
15. Weinberger DM, Trzcinski K, Lu YJ, Bogaert D, Brandes A, Galagan J, Anderson PW, Malley R, Lipsitch M. 2009 Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 5, e1000476. (doi:10.1371/journal.ppat.1000476)
16. Borrow R, Heath PT, Siegrist C-A. 2012 Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr. Opin. Infect. Dis. 25, 292-303. (doi:10.1097/QCO.0b013e3283531b0f)
17. Feldman C, Anderson R. 2014 Review: current and new generation pneumococcal vaccines. J. Infect. 69, 309-325. (doi:10.1016/j.jinf.2014.06.006)
18. Avci FY, Li X, Tsuji M, Kasper DL. 2011 A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat. Med. 17, 1602-1609. (doi:10.1038/nm.2535)
19. Frasch CE 2009 Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges. Vaccine 27, 6468-6470. (doi:10.1016/j.vaccine.2009.06.013)
20. Feldman MF et al. 2005 Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc. Natl Acad. Sci. USA 102, 3016-3021. (doi:10.1073/pnas.0500044102)
21. Cuccui J et al. 2013 Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol. 3, 130002. (doi:10.1098/rsob.130002)
22. Garcia-Quintanilla F, Iwashkiw JA, Price NL, Stratilo C, Feldman MF. 2014 Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery. Front. Microbiol. 5, 381. (doi:10.3389/fmicb.2014.00381)
23. Kämpf MM, Braun M, Sirena D, Ihssen J, Thöny-Meyer L, Ren Q. 2015 In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation. Microb. Cell Fact 14, 12. (doi:10.1186/s12934-015-0195-7)
24. Wacker M et al. 2014 Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli. J. Infect. Dis. 209, 1551-1561. (doi:10.1093/infdis/jit800)
25. Yother J. 2011 Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu. Rev. Microbiol. 65, 563-581. (doi:10.1146/annurev. micro.62.081307.162944)
26. Cartee RT, Forsee WT, Jensen JW, Yother J. 2001 Expression of the Streptococcus pneumoniae type 3 synthase in Escherichia coli: assembly of type 3 polysaccharide on a lipid primer. J. Biol. Chem. 276, 48 831-48 839. (doi:10.1074/jbc.M106481200)
27. García E, López R. 1997 Molecular biology of the capsular genes of Streptococcus pneumoniae. FEMS Microbiol. Lett. 149, 1-10. (doi:10.1016/S0378-1097(97)00026-8)
28. Bentley SD et al. 2006 Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2, e31. (doi:10.1371/journal.pgen.0020031)
29. Kamerling JP 2000 Pneumococcal polysaccharides: a chemical view. In Streptococcus pneumoniae: molecular biology and mechanisms of disease (ed. A Tomasz), pp. 81-114. Larchmont, New York: Mary Ann Liebert, Inc.
30. Aanensen DM, Mavroidi A, Bentley SD, Reeves PR, Spratt BG. 2007 Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci. J. Bacteriol. 189, 7856-7876. (doi:10.1128/JB.00837-07)
31. Saito H, Miura KI. 1963 Preparation of transforming deoxyribonucleic acid by phenol treatment. Biochim. Biophys. Acta 72, 619-629. (doi:10.1016/0926-6550(63)90386-4)
32. Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, Roop RM, Peterson KM. 1995 Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166, 175-176. (doi:10.1016/0378-1119(95)00584-1)
33. Osoegawa K, de Jong PJ, Frengen E, Ioannou PA. 2001 Construction of bacterial artificial chromosome (BAC/PAC) libraries. In Current Protocols in Human Genetics (eds NC Dracopoli et al.), Ch. 5, Unit 5.15. Hoboken, NJ: Wiley.
34. Bachmann BJ 1996 Derivations and genotypes of some mutant derivatives of Escherichia coli K-12. In Escherichia coli and Salmonella cellular and molecular biology (ed. FC Neidhardt), pp. 2460-2488. 2nd edn. Washington, DC: ASM Press.
35. Davis MR, Goldberg JB. 2012 Purification and visualization of lipopolysaccharide from Gramnegative bacteria by hot aqueous-phenol extraction. J. Vis. Exp. 63, e3916.
36. Manat G, Roure S, Auger R, Bouhss A, Barreteau H, Mengin-Lecreulx D, Touzé T. 2014 Deciphering the metabolism of undecaprenyl-phosphate: the bacterial cell-wall unit carrier at the membrane frontier. Microb. Drug Resist. 20, 199-214. (doi:10.1089/mdr.2014.0035)
37. Saksouk N, Pelosi L, Colin-Morel P, Boumedienne M, Abdian PL, Geremia RA. 2005 The capsular polysaccharide biosynthesis of Streptococcus pneumoniae serotype 8: functional identification of the glycosyltransferase WciS (Cap8H). Biochem. J. 389, 63-72. (doi:10.1042/BJ20050217)
38. Pelosi L, Boumedienne M, Saksouk N, Geiselmann J, Geremia RA. 2005 The glucosyl-1-phosphate transferase WchA (Cap8E) primes the capsular polysaccharide repeat unit biosynthesis of Streptococcus pneumoniae serotype 8. Biochem. Biophys. Res. Commun. 327, 857-865. (doi:10.1016/j.bbrc.2004.12.082)
39. Wacker M et al. 2006 Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc. Natl Acad. Sci. USA 103, 7088-7093. (doi:10.1073/pnas.0509207103)
40. Morona JK, Miller DC, Morona R, Paton JC. 2004 The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. J. Infect. Dis. 189, 1905-1913. (doi:10.1086/383352)
41. Guidolin A, Morona JK, Morona R, Hansman D, Paton JC. 1994 Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F. Infect. Immun. 62, 5384-5396.
42. Pelkonen S, Häyrinen J, Finne J. 1988 Polyacrylamide gel electrophoresis of the capsular polysaccharides of Escherichia coli K1 and other bacteria. J. Bacteriol. 170, 2646-2653.
43. Kim JO, Weiser JN. 1998 Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177, 368-377. (doi:10.1086/514205)
44. Linton D et al. 2005 Functional analysis of the Campylobacter jejuni N-linked protein glycosylation pathway. Mol. Microbiol. 55, 1695-1703. (doi:10.1111/j.1365-2958.2005.04519.x)
45. Nayak AR, Tinge SA, Tart RC, McDaniel LS, Briles DE, Curtiss R. 1998 A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect. Immun. 66, 3744-3751.
46. Moffitt KL, Yadav P, Weinberger DM, Anderson PW, Malley R. 2012 Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine. Vaccine 30, 4316-4322. (doi:10.1016/j.vaccine.2012.01.034)
47. Gonçalves VM et al. 2014 Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability. Vaccine 32, 1113-1120. (doi:10.1016/j.vaccine.2013.10.091)
48. H17-mediated protection against pneumococcal carriage by a whole-cell vaccine is dependent on Toll-like receptor 2 and surface lipoproteins. Clin. Vaccine Immunol. 22, 909-916. (doi:10.1128/CVI.00118-15)
49. Oster P, Lennon D, O'Hallahan J, Mulholland K, Reid S, Martin D. 2005 MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 23, 2191-2196. (doi:10.1016/j.vaccine.2005.01.063)
50. Muralinath M, Kuehn MJ, Roland KL, Curtiss R. 2011 Immunization with Salmonella enterica Serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect. Immun. 79, 887-894. (doi:10.1128/IAI.00950-10)
51. Navarro Torné A, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJA, Pastore-Celentano L. 2014 European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. Vaccine 32, 3644-3650. (doi:10.1016/j.vaccine.2014.04.066)
52. Pilishvili T et al. 2010 Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201, 32-41. (doi:10.1086/648593)
53. Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MPE, Miller E. 2015 Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect. Dis. 15, 535-543. (doi:10.1016/S1473-3099(15)70044-7)
54. Morona JK, Paton JC, Miller DC, Morona R. 2000 Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol. Microbiol. 35, 1431-1442. (doi:10.1046/j.1365-2958.2000.01808.x)
55. Bender MH, Cartee RT, Yother J. 2003 Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae. J. Bacteriol. 185, 6057-6066. (doi:10.1128/JB.185.20.6057-6066.2003)
56. Wugeditsch T, Paiment A, Hocking J, Drummelsmith J, Forrester C, Whitfield C. 2001 Phosphorylation of Wzc, a tyrosine autokinase, is essential for assembly of group 1 capsular polysaccharides in Escherichia coli. J. Biol. Chem. 276, 2361-2371. (doi:10.1074/jbc.M009092200)
57. Hagelueken G, Huang H, Mainprize IL, Whitfield C, Naismith JH. 2009 Crystal structures of Wzb of Escherichia coli and CpsB of Streptococcus pneumoniae, representatives of two families of tyrosine phosphatases that regulate capsule assembly. J. Mol. Biol. 392, 678-688. (doi:10.1016/j.jmb.2009.07.026)
58. Paoletti LC, Kasper DL, Michon F, DiFabio J, Jennings HJ, Tosteson TD, Wessels MR. 1992 Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J. Clin. Invest. 89, 203-209. (doi:10.1172/JCI115564)
59. Wessels MR, Kasper DL. 1989 Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide. J. Exp. Med. 169, 2121-2131. (doi:10.1084/jem.169.6.2121)
60. Peeters CCAM, Tenbergen-Meekes A, Evenberg DE, Poolman JT, Zegers BJM, Rijkers GT. 1991 A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J. Immunol. 146, 4308-4314.
61. Marolda CL, Vicarioli J, Valvano MA. 2004 Wzx proteins involved in biosynthesis of O antigen function in association with the first sugar of the O-specific lipopolysaccharide subunit. Microbiology 150, 4095-4105. (doi:10.1099/mic.0. 27456-0)
62. Marolda CL, Tatar LD, Alaimo C, Aebi M, Valvano MA. 2006 Interplay of the Wzx translocase and the corresponding polymerase and chain length regulator proteins in the translocation and periplasmic assembly of lipopolysaccharide O antigen. J. Bacteriol. 188, 5124-5135. (doi:10.1128/JB.00461-06)
63. Hong Y, Cunneen MM, Reeves PR. 2012 The Wzx translocases for Salmonella enterica O-antigen processing have unexpected serotype specificity. Mol. Microbiol. 84, 620-630. (doi:10.1111/j.1365-2958.2012.08048.x)
64. Liu MA, Stent TL, Hong Y, Reeves PR. 2015 Inefficient translocation of a truncated O unit by a Salmonella Wzx affects both O-antigen production and cell growth. FEMS Microbiol. Lett. 362, fnv053. (doi:10.1093/femsle/fnv053)
65. Hong Y, Reeves PR. 2014 Diversity of O-antigen repeat unit structures can account for the substantial sequence variation of Wzx translocases. J. Bacteriol. 196, 1713-1722. (doi:10.1128/JB. 01323-13)
66. Erbel PJA, Barr K, Gao N, Gerwig GJ, Rick PD, Gardner KH. 2003 Identification and biosynthesis of cyclic enterobacterial common antigen in Escherichia coli. J. Bacteriol. 185, 1995-2004. (doi:10.1128/JB. 185.6.1995-2004.2003)
67. Guo H, Feng L, Tao J, Zhang C, Wang L. 2004 Identification of Escherichia coli O172 O-antigen gene cluster and development of a serogroup-specific PCR assay. J. Appl. Microbiol. 97, 181-190. (doi:10.1111/j.1365-2672.2004. 02305.x)
68. Demendi M, Ishiyama N, Lam JS, Berghuis AM, Creuzenet C. 2005 Towards a better understanding of the substrate specificity of the UDP-N-acetylglucosamine C4 epimerase WbpP. Biochem. J. 389, 173-180. (doi:10.1042/BJ20050263)
69. Bernatchez S, Szymanski CM, Ishiyama N, Li J, Jarrell HC, Lau PC, Berghuis AM, Young NM, Wakarchuk WW. 2005 A single bifunctional UDP-GlcNAc/Glc 4-epimerase supports the synthesis of three cell surface glycoconjugates in Campylobacter jejuni. J. Biol. Chem. 280, 4792-4802. (doi:10.1074/jbc.M407767200)
70. Studier FW, Daegelen P, Lenski RE, Maslov S, Kim JF. 2009 Understanding the differences between genome sequences of Escherichia coli B strains REL606 and BL21(DE3) and comparison of the E. coli B and K-12 genomes. J. Mol. Biol. 394, 653-680.
71. Cuccui J, Wren BW. 2013 Bacteria like sharing their sweets. Mol. Microbiol. 89, 811-815. (doi:10.1111/mmi.12328)
72. Iwashkiw JA et al. 2012 Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog. 8, e1002758. (doi:10.1371/journal.ppat.1002758)
73. MacLachlan PR, Keenleyside WJ, Dodgson C, Whitfield C. 1993 Formation of the K30 (group I) capsule in Escherichia coli O9:K30 does not require attachment to lipopolysaccharide lipid A-core. J. Bacteriol. 175, 7515-7522.
74. Fisher AC et al. 2011 Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. Appl. Environ. Microbiol. 77, 871-881. (doi:10.1128/AEM.01901-10)
75. McNeely TB, Staub JM, Rusk CM, Blum MJ, Donnelly JJ. 1998 Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9 V in humans and rhesus macaques. Infect. Immun. 66, 3705-3710.